9 Followers on Owler

Affinivax

Read more
Steven Brugger's photo - President & CEO of Affinivax

President & CEO

Steven Brugger

CEO Approval Rating

86/100

Founded:

2014

Status:

PrivateIndependent Company

Est. Annual Revenue
<$1M
Agree?
Est. Employees
70
Agree?

Affinivax News

Affinivax Press Releases

Social Media

Affinivax Headquarters

301 Binney St Suite 302

Cambridge, Massachusetts02142

617-465-0865

Driving Directions »

Affinivax Summary

ABOUT

Overview

Affinivax is a clinical-stage biopharma company that develops and commercializes novel MAPS vaccines for the treatment of infectious diseases. Affinivax was founded in 2014. Affinivax's headquarters is located in Cambridge, Massachusetts, USA 02142. I...

CEO

Affinivax's President & CEO, Steven Brugger, currently has an approval rating of 86%. Affinivax's primary competitors are Oragenics, Paratek & Melinta.

Acquisitions

There have been no acquisitions found related to Affinivax

Investments

Recent investment data cannot be found related to Affinivax

Frequently Asked Questions about Affinivax

  1. When was Affinivax founded?

    Affinivax was founded in 2014
  2. Who is Affinivax's CEO?

    Affinivax's CEO is Steven Brugger
  3. How much revenue does Affinivax generate?

    Affinivax generates $ < 1M in revenue
  4. How much funding does Affinivax have?

    Affinivax has historically raised $359.5M in funding
  1. Where is Affinivax's headquarters?

    Affinivax's headquarters is in Cambridge Massachusetts, USA
  2. How many employees does Affinivax have?

    Affinivax has 70 employees
  3. What sector does Affinivax operate in?

    Affinivax is in Biotechnology, Pharmaceuticals
  4. Who are Affinivax's competitors?

    Affinivax's top competitors are Oragenics, Paratek, Melinta

Trending Companies